摘要
目的分析护患共同管理模式对胺碘酮治疗心律失常患者生命体征及静脉炎发生率的影响。方法选取2018年5月—2020年3月大连医科大学附属第一医院收治的采用胺碘酮治疗的心律失常患者114例,按照随机数字表法分为研究组(n=57)与对照组(n=57),对照组采用常规护理,研究组采用护患共同管理模式干预。对比2组生命体征、静脉炎发生情况、毒副反应发生情况及护理满意度。结果干预后,2组收缩压、心跳频率均较干预前降低,但研究组高于对照组(P<0.05);研究组静脉炎发生率5.26%(3/57),低于对照组的33.33%(19/57)(P<0.05);研究组毒副反应发生率7.02%(4/57),低于对照组的21.05%(12/57)(P<0.05);研究组护理满意度98.25%(56/57),高于对照组的73.68%(42/57)(P<0.05)。结论护患共同管理模式应用于胺碘酮治疗心律失常患者中,可改善生命体征,降低静脉炎发生率和毒副反应发生率,并能提升患者护理满意度,值得临床推广。
Objective To analyze the effect of nursing co-management mode on the incidence of vital signs and phlebitis in amiodarone treatment in arrhythmia patients.Methods 114 arrhythmia patients with amiodarone in May 2018 in March 2020 were divided into study group(n=57)and control group(n=57),using common management mode of vital signs,phlebitis and toxic side reactions.Results After intervention,both systolic and heartbeat rates were lower than before intervention,but the group was higher than control(P<0.05);phlebitis was 5.26%(3/57)below 33.33%(19/57)(P<0.05),and 7.02%(4/57)lower than 21.05%(12/57)(P<0.05).Conclusion The common management mode in amiodarone can improve the vital signs,reduce the incidence of phlebitis and toxic side reaction,which is worth clinical promotion.
作者
法卿
殷涵
杨越
Fa Qing;Yin Han;Yang Yue(The first affiliated hospital of Dalian medical university,Liaoning 116011)
出处
《基层医学论坛》
2023年第9期18-20,30,共4页
The Medical Forum
